<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00788242</url>
  </required_header>
  <id_info>
    <org_study_id>NAC 08-032</org_study_id>
    <nct_id>NCT00788242</nct_id>
  </id_info>
  <brief_title>The Effect of Glucose-Insulin-Potassium Infusion in Patients Undergoing Cardiac Surgery</brief_title>
  <official_title>The Effect of Glucose-Insulin-Potassium Infusion on Myocardial Injuries and Cardiac Function in Patients Undergoing Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Christoph Ellenberger</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the cardioprotective effects of a short term
      infusion of glucose-insulin-potassium (GIK) during heart surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiac surgery with cardiopulmonary bypass and ischemic cardiac arrest is associated with a
      wide spectrum of perioperative myocardial ischemic-reperfusion injuries resulting in
      significant cardiac morbidity, namely contractile dysfunction, myocardial infarction, and low
      cardiac output syndrome requiring prolonged intensive care and hospital stay. The infusion of
      glucose-insulin-potassium (GIK) is one of the oldest cardioprotective interventions during
      cardiac surgery. Although experimental evidence is strong, clinical data remain conflicting.
      We will investigate the impact of short term GIK on the extent of myocardial injuries as well
      as on the left-ventricular systolic and diastolic function in 2 high-risk groups of cardiac
      surgical patients: Patients with cardiac dysfunction undergoing aortocoronary bypass surgery
      and patients with severe aortic stenosis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postcardiotomy ventricular dysfunction</measure>
    <time_frame>48h postoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Systolic and diastolic cardiac function using transoesophageal echocardiography</measure>
    <time_frame>intraoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypo-/hyperglycemia Hypo-/hyperkaliemia</measure>
    <time_frame>intraoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serious cardiovascular adverse events (myocardial infarction, cardiac arrhythmia, low cardiac output, stroke)</measure>
    <time_frame>48 postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum troponin and creatinine kinase</measure>
    <time_frame>Intraoperative - 48 h postoperative</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Aortic Stenosis</condition>
  <condition>Coronary Heart Disease</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Administration of glucose-insulin-potassium</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glucose-insulin-potassium</intervention_name>
    <description>20 IU of insulin and 10 mM of KCl mixed with 50 ml of 40% Glucose. Administration of 0.8 ml/kg/h over 60 min before aortic cross-clamping</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>60 ml of isotonic saline. Administration of 0.8 ml/kg/h over 60 min before aortic cross-clamping</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Severe aortic stenosis

          -  Coronary artery disease associated with poor left ventricular function

          -  Parsonnet score &gt;7

        Exclusion Criteria:

          -  Dementia or inability to understand the study protocol

          -  Off-pump and emergent cardiac surgery

          -  Poorly controlled diabetes mellitus

          -  Severe renal insufficiency

          -  Abnormal liver function Child-Plugh - C

          -  Body Mass Index &lt; 18 and &gt; 35
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cardiocentro</name>
      <address>
        <city>Lugano</city>
        <state>Ticino</state>
        <zip>6900</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geneva University Hospital</name>
      <address>
        <city>Geneva</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2008</study_first_submitted>
  <study_first_submitted_qc>November 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2008</study_first_posted>
  <last_update_submitted>November 22, 2016</last_update_submitted>
  <last_update_submitted_qc>November 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Geneva</investigator_affiliation>
    <investigator_full_name>Christoph Ellenberger</investigator_full_name>
    <investigator_title>MÃ©decin Adjoint</investigator_title>
  </responsible_party>
  <keyword>Cardiac surgery</keyword>
  <keyword>Cardioprotection</keyword>
  <keyword>Aortocoronary bypass graft</keyword>
  <keyword>Aortic stenosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

